The Single Best Strategy To Use For AS1842856
This can be a preview of membership content material, log in via an institution to examine entry. Accessibility this chapterInitially-in-human review of your PARP/tankyrase inhibitor E7449 in people with advanced sound tumours and analysis of a novel drug-response predictor LUM/IVA is the initial remedy specifically indicated for the procedure of